olaparib,abemaciclib,niraparib,ribociclib
eli lilly,novartis,astrazeneca,merck
['ovarian', 'verzenio', 'lynparza', 'kisqali', 'breast', 'zejula', 'novartis', 'eli lilly', ' lilly']
i see this novartis' kisqali v. eli lilly's verzenio rivalry in early-stage hr+/her2- breast cancer to potentially evolve into a zejula vs. lynparza situation in ovarian cancer. #asco23 
Biopharma follower @FiercePharma & @FierceBiotech. Medill MSJ 16